These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31139865)

  • 1. [Anal funnels and wonder pills-the dubious market for medical products in the Federal Republic of Germany until 1965].
    Mildenberger FG
    Urologe A; 2019 Oct; 58(10):1201-1206. PubMed ID: 31139865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [THE NEW DRUG LAW OF THE GERMAN DEMOCRATIC REPUBLIC AND ITS SIGNIFICANCE IN THE EVALUATION OF DRUGS].
    RICHTER J
    Dtsch Stomatol; 1965 May; 15():366-88. PubMed ID: 14314524
    [No Abstract]   [Full Text] [Related]  

  • 3. Legal requirements for the use of phytopharmaceutical drugs in the Federal Republic of Germany.
    Keller K
    J Ethnopharmacol; 1991 Apr; 32(1-3):225-9. PubMed ID: 1881161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some implications of legalized substitution of prescribed pharmaceuticals.
    PARKER JM
    Can Med Assoc J; 1962 Dec; 87(25):1318-21. PubMed ID: 13941488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Herbal medicine products and drug law].
    Kraft K
    Forsch Komplementarmed; 1999 Feb; 6(1):19-23. PubMed ID: 10213877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [PHARMACY OWNERSHIP IN THE GERMAN FEDERAL REPUBLIC].
    HARDERWIJK ED
    Pharm Weekbl; 1964 Oct; 99():1245-50. PubMed ID: 14322668
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cannabis for medical purposes : Impact of the law of 6 March 2017 on physicians].
    Cremer-Schaeffer P; Knöss W; Broich K
    Schmerz; 2019 Oct; 33(5):378-383. PubMed ID: 31243538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [PROBLEMS OF DRUG LEGISLATION. (ON THE NEW DRUG LAW IN THE GERMAN DEMOCRATIC REPUBLIC)].
    OEHME P
    Z Arztl Fortbild (Jena); 1964 Sep; 58():996-9. PubMed ID: 14339579
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE PHYSICIAN IN MEDIEVAL LAW].
    MICKEL J
    Offentl Gesundheitsdienst; 1965; 27():217-24. PubMed ID: 14306959
    [No Abstract]   [Full Text] [Related]  

  • 11. [The drug law and its significance for the activities of public health physicians].
    HOLTZEM H
    Offentl Gesundheitsdienst; 1963 Mar; 25():133-44. PubMed ID: 13961479
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medical problems and risks with the discount contract law changeover of inhalers in Germany].
    Korupp A
    Dtsch Med Wochenschr; 2008 Sep; 133(37):1857; author reply 1857-8. PubMed ID: 18770488
    [No Abstract]   [Full Text] [Related]  

  • 13. [The objection to drug trials by salaried physicians on grounds of conscience. The judgement of the Labor Court of the Federal Republic of Germany of 24 May 1989].
    Rieger HJ
    Dtsch Med Wochenschr; 1990 Jun; 115(24):954-6. PubMed ID: 2357930
    [No Abstract]   [Full Text] [Related]  

  • 14. [Duties of the physician in the context of the current law on medical products].
    Kaiser RH; Ininger G
    Unfallchirurg; 2003 Mar; 106(3):226-36; quiz 236-7. PubMed ID: 12733501
    [No Abstract]   [Full Text] [Related]  

  • 15. [INTERPRETATION OF THE CONCEPT OF COMMUNICABLE SKIN DISEASES UNDER THE GERMAN FEDERAL REPUBLIC LAW ON INFECTIOUS DISEASES, PARAGRAPH 17, SECTION 2].
    TESSIN K
    Offentl Gesundheitsdienst; 1963 Jul; 25():330-3. PubMed ID: 14050383
    [No Abstract]   [Full Text] [Related]  

  • 16. [Crucial points of the future drug law in the Federal Republic of Germany].
    Hasskarl H
    Med Klin; 1975 Apr; 70(14):633-6. PubMed ID: 1152798
    [No Abstract]   [Full Text] [Related]  

  • 17. Strategies for a risky business: How drug dealers manage customers, suppliers and competitors in Italy, Slovenia and Germany.
    Tzvetkova M; Pardal M; Disley E; Rena A; Talic S; Forberger S
    Int J Drug Policy; 2016 May; 31():90-8. PubMed ID: 27161385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality control of drug prescriptions by positive lists--the European Formulary.
    Glaeske G
    Int J Clin Pharmacol Ther; 1994 Aug; 32(8):403-8. PubMed ID: 7981924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [THE NEW DRUG LAW OF THE GERMAN DEMOCRATIC REPUBLIC].
    BERTLING D
    Pharm Prax; 1964; 11():177-80. PubMed ID: 14328549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.